Cancer Precision Medicine Research

Our Cancer Precision Medicine Research Program:

• Sequences tumors from high-risk solid tumor and hematological malignancy patients in collaboration with Ashion Analytics, a Certified Authorization Professional (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical genomics testing laboratory based in Phoenix, AZ.

• Conducts a bimonthly multidisciplinary Molecular Tumor Board to discuss sequencing results with clinicians, pathologists and basic scientists.

• Researches new precision medicine approaches in the areas of brain tumors, solid tumors, and leukemia and lymphoma.

Our cancer precision medicine team:

• Craig Castellino, MD

• Sharon Castellino, MD, MSc

• Thomas Cash, MD, MSc

• Kelly Goldsmith, MD

• Douglas Graham, MD, PhD

• Anna Kenney, PhD

• Tobey MacDonald, MD

• Melinda Pauly, MD

• Christopher Porter, MD

• Ryan Summers, MD

• Daniel Wechsler, MD, PhD